Staphylococcus Aureus Bacteremia
📧 Sign up to get email alerts when something new happens for Staphylococcus Aureus Bacteremia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia [Phase 1, Phase 2]
This clinical trial update reports results from a Phase 1/2 study evaluating intravenous AP-SA02 for safety, tolerability, and efficacy in s…
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: Non-inferiority Trial Comparing Cloxacillin vs Cefazolin in Methicillin-susceptible Staphylococcus Aureus Bacteremia [NA]
A completed non-inferiority trial comparing cloxacillin to cefazolin for methicillin-susceptible Staphylococcus aureus bacteremia has been r…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: Staphylococcus Aureus Bacteraemia (SAB)-Support-Study [NA]
The SAB-Support-Study for Staphylococcus aureus bacteremia sponsored by University Medicine Greifswald has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: An Evaluation of a Antimicrobial Stewardship Recommendation Bundle for Staphylococcus Aureus Bloodstream Infections
Clinical trial update evaluating an antimicrobial stewardship recommendation bundle for Staphylococcus aureus bloodstream infections.
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Safety & Efficacy of True Human Antibody, 514G3, in Staphylococcus Aureus Bacteremia Hospitalized Subjects. [Phase 1, Phase 2]
Clinical trial update reporting safety and efficacy results for the true human antibody 514G3 in adults with Staphylococcus aureus bacteremi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia [Phase 2]
Phase 2 trial evaluating dalbavancin for Staphylococcus aureus bacteremia has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: Direct Lysis of Staph Aureus Resistant Pathogen Trial of Exebacase [Phase 3]
Phase 3 trial of exebacase for direct lysis of Staphylococcus aureus showing terminated status with results posted.
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia [Phase 3]
A Phase 3 trial evaluating ceftobiprole for Staphylococcus aureus bacteremia has completed, with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2021-10-08Clinical Trial Update: Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia [Phase 2]
Phase 2 trial evaluating CF-301 (oritavancin-like agent) added to antibacterial therapy for Staphylococcus aureus bacteremia and endocarditi…
-
CLINICAL_TRIALS trial_result · 2021-08-17Clinical Trial Update: Phase IIa Clinical Study of N-Rephasin® SAL200 [Phase 2]
Phase IIa trial of N-Rephasin SAL200 was terminated; results posted in 2021 for Staphylococcus aureus bacteremia treatment.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Seven Versus Fourteen Days of Treatment in Uncomplicated Staphylococcus Aureus Bacteremia [Phase 4]
A Phase 4 trial update comparing seven versus fourteen days of treatment for uncomplicated Staphylococcus aureus bacteremia.
-
CLINICAL_TRIALS trial_result · 2020-09-22Clinical Trial Update: Daptomycin as Adjunctive Therapy for Staphylococcus Aureus Bacteremia [Phase 4]
Phase 4 clinical trial evaluating daptomycin as adjunctive therapy for methicillin-susceptible Staphylococcus aureus bacteremia has complete…
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial [Phase 3]
Phase 3 trial evaluating telavancin for Staphylococcus aureus bacteremia was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Safety & Efficacy of Daptomycin Versus Standard of Care (SOC) in 1 - 17 Year Olds With Staphylococcus Aureus Bacteremia (MK-3009-005) [Phase 4]
Phase 4 trial comparing daptomycin to standard of care in pediatric patients (1-17 years) with Staphylococcus aureus bacteremia; study compl…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Direct Thrombin Inhibitors Versus LMWH in Staphylococcus Aureus Bacteraemia [Phase 2]
Phase 2 trial comparing direct thrombin inhibitors to low molecular weight heparin in patients with Staphylococcus aureus bacteremia has com…
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Vancomycin Versus Daptomycin for the Treatment of Methicillin Resistant Staphylococcus Aureus (MRSA) Bacteremia [Phase 2]
Phase 2 randomized trial comparing vancomycin with daptomycin for Staphylococcus aureus bacteremia has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-08-07Clinical Trial Update: Efficacy of a Short-term Sequential Therapy in Non-complicated Catheter Related Bacteremia by Methicillin- Susceptible S.Aureus. [Phase 3]
Phase 3 trial evaluating short-term sequential therapy for non-complicated catheter-related bloodstream infection due to methicillin-suscept…
-
CLINICAL_TRIALS trial_result · 2014-12-05Clinical Trial Update: Staphylococcus Aureus Bacteremia: Impact of an Intervention Program in Improving the Clinical Management and Review of the Clinical and Molecular Epidemiology
This clinical trial update describes an intervention program aimed at improving clinical management and the molecular epidemiology review of…
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: Safety and Efficacy Study of Ceftaroline in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia [Phase 4]
Phase 4 safety and efficacy study of ceftaroline for Staphylococcus aureus bacteremia and MRSA bacteremia has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-29Clinical Trial Update: Clinical Trial Comparing Safety and Pharmacokinetics of Standard Antibiotic Therapy, Plus Aurexis® or Placebo, for Treatment of Staphylococcus Aureus Bacteremia (SAB) [Phase 2]
A completed Phase 2 trial compared safety and pharmacokinetics of standard antibiotic therapy plus Aurexis versus placebo in Staphylococcus …
-
CLINICAL_TRIALS trial_result · 2012-05-14Clinical Trial Update: Safety and Behavior of S. Aureus Immune Globulin Intravenous(Human), [Altastaph] in Patients With S. Aureus Bacteremia and Continuing Fever [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trials evaluated the safety and behavior of Altastaph (Staphylococcus aureus immune globulin intravenous) in patien…
-
CLINICAL_TRIALS trial_result · 2011-05-12Clinical Trial Update: Comparison of Nephrotoxicity and Hospital Costs in Patients With Methicillin-Resistant Staphylococcus Aureus Bacteremia Who Received Vancomycin Versus Teicoplanin Therapy
This clinical trial update compares nephrotoxicity and hospital costs in patients with MRSA bacteremia treated with vancomycin versus teicop…
-
CLINICAL_TRIALS trial_result · 2011-03-22Clinical Trial Update: Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia [Phase 2]
A Phase 2 trial update on telavancin for uncomplicated Staphylococcus aureus bacteremia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2010-09-10Clinical Trial Update: Chart Review of Outcome of Treatment for S. Aureus Bacteremia
A completed chart-review study evaluating outcomes of treatment for Staphylococcus aureus bacteremia.
-
CLINICAL_TRIALS trial_result · 2007-10-23Clinical Trial Update: Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia
A completed clinical trial evaluating combination therapy with a fluoroquinolone for Staphylococcus aureus bacteremia.